ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 996,64
0,49%
Dow Jones
38 852,27
0,46%
DAX
18 175,21
1,01%
Brent Oil
83,395
-0,10%
Bitcoin
63 681,13
0,81%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. VYNE Therapeutics Inc (VYNE)

  7. VYNE Therapeutics Inc (VYNE) Actualités

VYNE VYNE Therapeutics Inc

2,71
0,09 (3,44%)
06 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
VYNE Therapeutics Inc VYNE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,09 3,44% 2,71 22:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,64 2,5801 2,7499 2,71 2,62
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/3/202423:16EDGAR2Form S-3 - Registration statement under Securities Act of..
01/3/202423:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202414:12EDGAR2Form 8-K - Current report
02/2/202415:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03/1/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202414:15EDGAR2Form 8-K - Current report
15/12/202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202323:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/12/202322:00EDGAR2Form 8-K - Current report
04/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
22/11/202322:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/11/202322:30EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202322:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/11/202321:59EDGAR2Form DEF 14A - Other definitive proxy statements
13/11/202313:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:46EDGAR2Form 8-K - Current report
02/11/202321:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
30/10/202312:30EDGAR2Form 8-K - Current report
04/10/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:00EDGAR2Form 8-K - Current report
05/7/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
VYNE
VYNE Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés